Also, elevated IL-33 levels may accelerate breast cancer progression indirectly through signaling molecules like COT (Carcinoma Osaka Thyroid), which stimulate inflammation in the tumor microenvironment and foster the malignant transformation of the mammary epithelium [60]. Here, IL33 is linked to breast carcinoma.